Article
Potential of lung surfactant proteins, SP-A and SP-D, and mannan binding lectin for therapy and genetic predisposition to allergic and invasive aspergillosis.
Recent patents on inflammation & allergy drug discovery - 1 Nov 2007
Madan Taruna
Abstract excerpt
A significant proportion of bronchial asthma patients have underlying pulmonary fungal infections that contribute to persistent inflammation and allergic reactions. Aspergillus fumigatus is a ubiquitous opportunistic fungal pathogen causing a spectrum of allergic and infectious diseases. Currently, oral corticosteroids form the first line of treatment for allergic aspergillosis and use of antifungals such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
